Unilife says its 15 year-wearable injector supply deal with Sanofi is “unprecendented” and could result in over $1bn of sales annually for the delivery device maker.
UK's MedPharm has received a Department of Trade and Industry (DTI)
grant for Research and Development to produce its new spray
treatment for eczema, expected to be available in the US by 2009.
In the wake of the divestment of its Dynamit Nobel chemicals
businesses, mg technologies of Germany has reported a modest
increase in sales for the first half of the year, helped by a good
performance from its GEA subsidiary.
Predictions that the generics industry will experience further
consolidation - made at the annual meeting of the International
Generic Pharmaceutical Alliance this week - have been swiftly
followed by the news that Sandoz is buying...
Gaining ground in the billion dollar safety needles and syringes
market US development stage company Maxxon has linked up with Texan
drug delivery manufacturer Globe Medical Tech for a run on millions
of syringes.